Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMDFrom Monoamines to Neurocircuits: Our Evolving Understanding of Depression

Neuroplasticity Offers New Avenues for Depression Treatment

The medical community is witnessing a paradigm shift in the understanding and treatment of depression. Traditionally viewed through the lens of chemical imbalances and cognitive biases, new research suggests that neuroplasticity could be the key to more effective treatment strategies. Dr. Joseph Goldberg, Clinical Professor of Psychiatry at the Icahn School of Medicine, delves into this emerging concept in a discussion with Dr. Charles Turck.

HCN Medical Memo
The evolving understanding of depression as a disease influenced by neuroplasticity opens up new avenues for treatment. This shift from a purely biochemical or cognitive model to one that includes the architecture of neural circuits could revolutionize how we approach therapy. It also offers the potential for more personalized, effective treatments that could be delivered through a variety of platforms, including digital and telehealth services.

Key Points:
  • Evolution of Understanding: Depression was initially understood as a chemical imbalance, focusing on neurotransmitters like serotonin, norepinephrine, and dopamine. Cognitive theories later introduced the role of negative thought patterns.
  • Neuroplasticity: The new focus is on neuroplasticity, which refers to the brain’s ability to reorganize its structure and functions. This concept suggests that depression may be a result of “faulty wiring” in the brain rather than just chemical imbalances.
  • Brain Regions: Two key areas, the prefrontal cortex and the limbic system, are thought to be imbalanced in depression. Strengthening the connections between these areas could be crucial for effective treatment.
  • Physician Perspectives: Dr. Goldberg emphasizes that this new understanding could lead to novel treatments targeting specific neurocircuits, potentially delivered through telehealth or digital platforms.

“And now with modern theories about the treatment of depression involving strategies that can enhance neuroplasticity, or the viability and strength of nerve cell connections in brain regions involved in processing emotional information, I think we have exciting possibilities for how we treat depression and how to deliver the treatment.”
– Dr. Joseph Goldberg, Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York City

Additional Points:
  • Cognitive Behavioral Therapy (CBT): Aaron Beck’s cognitive theory led to the development of CBT, which aims to correct faulty thinking patterns.
  • Treatment Delivery: The pandemic has accelerated the adoption of virtual and digital treatment delivery methods, such as psychotherapy apps, which could increase access to treatment.

More on Depression

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form